Lilly(Eli) & Co

NYSE:LLY   3:59:57 PM EDT
192.82
+4.62 (+2.46%)
4:00:00 PM EDT: $192.81 -0.01 (-0.01%)
Other Pre-Announcement

Lilly Delivers First-Quarter 2021 Financial Results, Adjusts 2021 Financial Guidance

Published: 04/27/2021 10:50 GMT
Lilly(Eli) & Co (LLY) - Lilly Delivers First-quarter 2021 Financial Results, Adjusts 2021 Financial Guidance.
Q1 Earnings per Share $1.49.
2021 EPS Guidance Lowered to Be in Range of $7.03 to $7.23 on a Reported Basis.
2021 Adjusted EPS to Be in Range of $7.80 to $8.00 on a Non-GAAP Basis.
Qtrly Adjusted Earnings per Share $1.87.
Q1 Worldwide Trulicity Revenue Was $1.452 Billion, an Increase of 18 % Compared With Q1 2020.
Q1 of 2021, Worldwide Revenue Was $6.806 Billion, an Increase of 16 Percent Compared With Q1 of 2020.
Q1 of 2021, Worldwide Taltz Revenue Decreased 9 Percent Compared With Q1 of 2020, to $403.2 Million.
Now Anticipates 2021 Revenue to Be Between $26.6 Billion and $27.6 Billion.company Expects Mid-single Digit Net Price Declines Globally in 2021.
Qtrly Worldwide Humalog Revenue Decreased 11% to $617.0 Million.
Q1 Earnings per Share View $2.13, Revenue View $6.99 Billion -- Refinitiv Ibes Data (analyst estimates).
Qtrly Revenue From Covid-19 Antibodies $810.1 Million.
FY2021 Earnings per Share View $8.32, Revenue View $27.69 Billion -- Refinitiv Ibes Data (analyst estimates).
2021 Financial Guidance on a Non-GAAP Basis Reflects Primarily Lower Expected Revenue From Covid-19 Antibody Sales.